North China Pharmaceutical (SHA:600812) subsidiary Xiantai Pharmaceutical received a good manufacturing practice compliance certificate from the Spanish Agency of Medicines and Medical Products.
This certification grants approval for the company's sterile amoxicillin active pharmaceutical ingredient to enter the European Union market, according to a Wednesday filing with the Shanghai bourse.